Identification of Gαi3 as a promising target for osteosarcoma treatment

Int J Biol Sci. 2022 Jan 24;18(4):1508-1520. doi: 10.7150/ijbs.68861. eCollection 2022.

Abstract

Sustained activation of multiple receptor tyrosine kinases (RTKs) simultaneously is vital for tumorigenesis and progression of osteosarcoma (OS). Gαi proteins recruitment to various RTKs mediates downstream oncogenic signaling activation. The expression, functions and underlying mechanisms of Gαi3 in human OS were examined. Expression of Gαi3 is robustly elevated in human OS tissues and is correlated with a poor overall survival. In patient-derived primary OS cells and immortalized lines (MG63 and U2OS), Gαi3 depletion, by shRNA and CRISPR/Cas9 strategies, robustly suppressed cell viability, proliferation and migration, while provoking G1-S arrest and apoptosis activation. Conversely, Gαi3 overexpressing ectopically can accelerate proliferation and migration of OS cells. In OS cells, Gαi3 immunoprecipitated with VEGFR2, FGFR, PGDFR and EGFR, mediating downstream cascade transduction. Akt-mTOR activation in primary OS cells was potently inhibited by Gαi3 shRNA, knockout or dominant negative mutation, but augmented after Gαi3 overexpression. In vivo studies showed that Gαi3 shRNA AAV (adeno-associated viruses) intratumoral injection largely inhibited the growth of subcutaneous xenografts of primary OS cells. Moreover, the growth of the Gαi3-knockout primary OS xenografts was much slower than that of OS xenografts with empty vector. In Gαi3-depleted OS xenografts tissues, Gαi3 downregulation and Akt-mTOR inactivation were detected. Taken together, overexpressed Gαi3 mediates RTK-Akt signaling to drive OS progression.

Keywords: Akt-mTOR; Gαi3; Osteosarcoma; Signaling; multiple receptor tyrosine kinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Bone Neoplasms* / genetics
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Humans
  • Osteosarcoma* / genetics
  • Osteosarcoma* / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA, Small Interfering
  • Receptor Protein-Tyrosine Kinases
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • RNA, Small Interfering
  • Receptor Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases